NEW YORK (GenomeWeb) – Globavir today announced a partnership with BioManguinhos, a division of the Oswaldo Cruz Foundation (Fiocruz), to evaluate the firm's PanGlob RT-PCR Dengue diagnostic assay.

Under the terms of the agreement, the partners will work together to evaluate and develop Globavir's PanGlob for commercial launch in Brazil.

Globavir said that the test is more sensitive in detecting Dengue virus from patient samples than other diagnostic assays and can detect it regardless of the virus' specific serotype.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.